Name
Peginterferon alfa-2b
Alternate Names
Sylatron
Abbreviations
None
Category
Biologic therapy (BRM, immunotherapy)
Subcategory
None
NSC Number
720033
Primary Site
Histology
None
Remarks
March 29, 2011: Received FDA approval as a new adjuvant treatment for melanoma with microscopic or gross nodal involvement.
Phase II CML
Phase II CML
Coding
This drug should be coded